600161.SH
Beijing Tiantan Biological Products Corp. Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 11.94
−1.73%Sep 7, 2026, 09:25 UTC
Tiantan Biological's four subsidiaries received single plasma collection licenses from the Gansu Provincial Health Commission, allowing them to operate.
Source:Aug 28, 2026, 09:18 UTC
Tiantan Biological announced a cash dividend of 1 yuan per 10 shares (tax included) based on the total share capital of 1.977 billion shares as of the end of June 2026, with a total dividend amount of 198 million yuan (tax included).
Source:Jul 14, 2026, 10:54 UTC
Tiantan Biological announced its semi-annual net profit for 2026, reporting a significant decline.